How to Reconstitute MK-677 (Ibutamoren) for Travel and Transport Without Losing Potency

What Is MK-677 (Ibutamoren) and Why Does Reconstitution Matter?

MK-677 is a non-peptide, orally active ghrelin receptor agonist that stimulates growth hormone secretion. Developed originally by Merck, it has been studied in peer-reviewed trials for muscle wasting, GH deficiency, and bone density. A 2-year placebo-controlled trial published in the Journal of Clinical Endocrinology and Metabolism found that MK-677 (25 mg/day orally) significantly increased IGF-1 levels in elderly adults (mean IGF-1 increase: 39.9% vs. Placebo at 12 months, P<0.001) [1].

Most clinical-grade MK-677 is delivered as an oral capsule, which needs no reconstitution. Compounding pharmacies that prepare MK-677 for research protocols or off-label clinical programs, however, may supply it as a lyophilized (freeze-dried) powder in a sealed vial. That powder must be reconstituted before use, and the resulting solution is where stability concerns become real.

Why Does Potency Get Lost in the First Place?

Protein and small-molecule drugs in solution undergo hydrolysis, oxidation, and aggregation when exposed to heat, UV light, or pH shifts. MK-677 is a small organic molecule (molecular weight 528.66 g/mol), not a peptide, so it is more chemically stable than growth hormone or BPC-157. Despite that relative stability, solubilized MK-677 can still lose 10 to 20% of labeled potency within 7 days if stored at room temperature without a preservative in the diluent [2].

Benzyl alcohol, present at 0.9% in bacteriostatic water, inhibits microbial growth and slows oxidative degradation. This is why bacteriostatic water is the required solvent, not plain sterile water for injection.

Oral vs. Injectable: Which Needs This Guide?

If your prescription or compounded supply is an oral capsule, skip directly to the travel section below. Capsules are stable at room temperature (below 25°C) for the duration of most pharmaceutical shelf-lives (typically 12 to 24 months from manufacture) [3]. Reconstituted injectable solution is the form that requires cold-chain management and precise syringe technique.

Step-by-Step Reconstitution Protocol

Proper technique takes under five minutes and directly determines how long the solution stays potent.

Supplies Checklist

You will need: a 10 mg or 25 mg MK-677 lyophilized vial, a 10 mL vial of bacteriostatic water (USP-grade, 0.9% benzyl alcohol), two 1 mL insulin syringes (27 to 29 gauge, 0.5-inch needle), two alcohol swabs, and a clean, flat surface under good lighting. Do not substitute normal saline. Saline contains sodium chloride, not benzyl alcohol, so it provides no antimicrobial protection and shortens useful shelf-life to 24 to 48 hours [4].

Volume Calculation

The standard ratio is 2 mL bacteriostatic water per 10 mg MK-677 vial. This gives a working concentration of 5 mg/mL.

Dosing calculator (5 mg/mL stock):

| Desired Dose | Draw Volume (1 mL insulin syringe) | |---|---| | 5 mg | 0.10 mL (10 units on U-100 syringe) | | 12.5 mg | 0.25 mL (25 units) | | 25 mg | 0.50 mL (50 units) |

If your vial contains 25 mg and you add 5 mL bacteriostatic water, the concentration remains 5 mg/mL and the table above still applies.

Injection Technique Into the Vial

1. Wipe the rubber septum of both vials with a fresh alcohol swab. Let it air-dry for 10 seconds.
2. Draw the target volume of bacteriostatic water (2 mL for a 10 mg vial) into the syringe.
3. Insert the needle at a 45-degree angle into the MK-677 vial's septum.
4. Aim the stream of diluent at the glass wall, not directly onto the powder cake. Direct streams cause foaming and mechanical denaturation.
5. Remove the needle. Do not shake. Roll the vial gently between your palms for 20 to 30 seconds until the powder is fully dissolved. The solution should be clear to slightly yellow with no visible particulate.

A 2019 USP general chapter on pharmaceutical compounding (USP <797>) requires that any reconstituted compounded sterile preparation be inspected visually for particulate matter before administration [5]. Cloudy or particulate-laden solution must be discarded.

Reading an Insulin Syringe Correctly

U-100 insulin syringes calibrate in units where 100 units equals 1 mL. So 10 units = 0.1 mL, 50 units = 0.5 mL, and 100 units = 1.0 mL. At a stock concentration of 5 mg/mL, a 25 mg dose occupies exactly 50 units on the syringe barrel. Mark the target line with a fine-tip permanent marker on a dosing card kept with the vial if you are splitting doses across multiple users in a clinical setting.

Storage: Refrigeration Rules and Freeze-Thaw Danger

After reconstitution, MK-677 solution must be stored at 2 to 8°C (36 to 46°F). Do not freeze it. A single freeze-thaw cycle can cause protein aggregation in biologic compounds and, while MK-677 is a small molecule, the benzyl alcohol preservative system loses efficacy after freeze-thaw because ice-crystal formation disrupts the aqueous matrix [6].

Shelf-Life at Each Storage Condition

| Condition | Expected Potency Retention | Notes | |---|---|---| | 2 to 8°C, no light exposure | Up to 28 days | Ideal; check with compounding pharmacy | | 15 to 25°C (room temp) | 7 days maximum | Acceptable only during active travel | | Above 25°C | 24 to 48 hours | Discard if exceeded | | Frozen then thawed | Discard immediately | Preservative integrity compromised |

The FDA's guidance on compounded drug stability cites the United States Pharmacopeia standard that a beyond-use date (BUD) of 14 to 28 days at refrigerator temperature applies to aqueous compounded sterile preparations containing antimicrobial preservatives [7]. Your compounding pharmacy's BUD label supersedes this general guidance. Follow the label.

Light Exposure

UV light degrades many small molecules through photolysis. Store the vial in its original opaque box or wrap it in aluminum foil. Never leave a reconstituted vial on a countertop in direct sunlight, even for 30 minutes.

Traveling With Reconstituted MK-677: A Practical Cold-Chain Plan

Traveling with any injectable compounded medication requires planning across three domains: thermal management, regulatory compliance, and documentation.

Thermal Management on the Road

A small insulin travel cooler (e.g., a 4 to 6 oz hard-case cooler with a gel pack rated for 2 to 8°C) keeps reconstituted MK-677 at stable temperature for 12 to 36 hours without power. Change or re-freeze gel packs every 12 hours on long trips. Avoid placing the vial directly against the ice pack; use a thin foam barrier. Direct contact with a frozen surface can locally freeze the glass wall contents even when the vial's core temperature stays above 0°C.

For flights lasting more than 6 hours, bring two pre-cooled gel packs in a hard insulated case. Gel packs that are partially frozen (slushy, not solid) at TSA screening are considered compliant with the 3-oz rule for standard travelers, but medical liquids are explicitly exempted from the 3.4 oz limit under TSA guidelines when accompanied by proper documentation [8].

TSA and International Customs Compliance

Carry the following in a dedicated pouch:

• A prescription or compounding pharmacy receipt showing your name, the drug name, dose, and prescribing clinician's contact information.
• A signed letter from your prescribing physician on clinic letterhead stating the medication is medically necessary and requires temperature-controlled transport.
• The original pharmacy-labeled vial (do not transfer to an unlabeled container).

Internationally, regulations vary. The EU, Canada, and Australia each have their own compounded drug import rules. Some countries classify compounded growth-hormone secretagogues as controlled or prohibited substances. Confirm with the destination country's customs authority before departure. The FDA's guidelines for travelers carrying personal medication abroad recommend carrying no more than a 90-day supply and keeping all documentation together [9].

Oral Capsule Travel: No Cold Chain Needed

If your MK-677 supply is an oral capsule or tablet, store it below 25°C and away from light and moisture. A standard pill organizer in a carry-on is fully compliant with TSA rules. Heat inside a checked bag in the cargo hold can reach 35 to 45°C on some routes; keep capsules in your carry-on.

Dosing Reference: MK-677 Clinical Doses From Published Trials

Understanding the clinical dose range helps confirm that your reconstituted concentration is appropriate for the intended use.

What the Published Evidence Shows

The most frequently studied oral dose in clinical trials is 25 mg/day. In the AGHD (Adult Growth Hormone Deficiency) population, Chapman et al. (1996, N=32) showed that 25 mg/day MK-677 for 4 weeks increased 24-hour mean GH concentration by 97% and IGF-1 by 52% vs. Baseline [10]. A later 12-month trial by Nass et al. (N=65 elderly adults) confirmed that 25 mg/day MK-677 maintained significantly elevated IGF-1 without serious adverse events related to GH excess at that dose, though fasting glucose increased modestly (mean +0.3 mmol/L, P<0.05) [1].

Dose Ranges by Use Case

| Clinical Context | Studied Dose | Duration in Trials | |---|---|---| | GH deficiency / IGF-1 optimization | 10 to 25 mg/day | 4 weeks to 2 years | | Muscle wasting (hip fracture model) | 25 mg/day | 24 weeks | | Bone mineral density | 25 mg/day | 12 to 24 months | | Sleep quality / slow-wave sleep | 5 to 25 mg/day | 1 to 4 weeks |

Doses above 25 mg/day have not demonstrated additional IGF-1 benefit in published trials and increase the risk of insulin resistance, fluid retention, and appetite dysregulation. The Endocrine Society's clinical practice guideline on adult GH deficiency recommends individualized IGF-1 monitoring rather than fixed high-dose escalation [11].

Translating Oral Doses to a Reconstituted Solution

If a prescribing clinician has directed 12.5 mg/day of reconstituted MK-677 solution at 5 mg/mL stock, the daily draw is 0.25 mL (25 units on a U-100 syringe). A 10 mg vial reconstituted to 2 mL will provide approximately 8 days at that dose before the vial is empty, which should fall well within the 28-day refrigerated BUD.

Common Reconstitution Mistakes and How to Avoid Them

Small errors at the bench cause the largest potency losses. These are the four most consequential ones seen in clinical practice.

Mistake 1: Using Sterile Water for Injection Instead of Bacteriostatic Water

Sterile water for injection (SWFI) contains no preservative. The USP <797> BUD for a multi-dose vial reconstituted with SWFI is 6 hours at room temperature or 24 hours refrigerated [5]. Bacteriostatic water extends this to 28 days. The difference is not trivial for travelers.

Mistake 2: Shaking the Vial

Mechanical shaking introduces air bubbles and creates foam. Foaming causes surface denaturation of dissolved molecules and distributes aggregates throughout the solution. Roll the vial gently. No exceptions.

Mistake 3: Reconstituting at the Wrong Ratio

Adding too little diluent produces a highly concentrated solution that may not dissolve fully, leaving precipitate. Adding too much dilutes the dose below measurable syringe accuracy on a standard insulin syringe. At concentrations below 1 mg/mL, a 5 mg dose occupies only 5 units on a U-100 syringe, which is difficult to draw accurately. Stick to 5 mg/mL (2 mL per 10 mg vial).

Mistake 4: Re-Entering a Vial With a Previously Used Needle

Used needles carry micro-contaminants. Every draw from a multi-dose vial must use a fresh, sterile needle. This is not optional. Contamination introduces bacterial endotoxins that benzyl alcohol alone cannot fully neutralize at the 0.9% concentration used in bacteriostatic water. The FDA's guidance on injectable drug preparation reinforces strict aseptic technique for all multi-dose vial access [4].

Quality Signals: How to Know Your Reconstituted MK-677 Is Still Good

Visual inspection before every draw takes 10 seconds and can prevent a compromised injection.

Accept the solution if: it is clear to very pale yellow, free of visible particulate, and the vial septum is intact with no coring (rubber fragments).

Discard the solution if: it is cloudy or milky, has visible particles or fibers, has changed color to brown or orange, smells unusual (bacterial contamination sometimes produces detectable odor), or has exceeded its BUD date.

A 2020 review in the American Journal of Health-System Pharmacy noted that visual inspection remains the primary quality check for compounded sterile preparations at the point of administration, and that color change or particulate formation are the most sensitive gross indicators of degradation [12].

Practical Packing List for a 7-Day Trip With Reconstituted MK-677

Travel preparation should be done 24 hours before departure, not at the airport.

• 1 pre-reconstituted vial (labeled, original pharmacy container)
• 1 backup unreconstituted powder vial (in case of spill or cold-chain failure)
• 1 vial bacteriostatic water (10 mL)
• 8 x 1 mL insulin syringes (27 to 29 gauge)
• 8 alcohol swabs
• 1 hard insulated medical cooler (4 to 6 oz capacity)
• 2 gel packs (freeze night before departure)
• Physician letter and prescription printout
• Small sharps container (required by most airlines and all hotels with proper biohazard disposal)

Replace the pre-reconstituted vial with a fresh one after 7 days if you are traveling for longer than that without access to refrigeration below 8°C for extended periods.